Pyridoxamine Supplement Research: Why This B6 Is Mad at Sugar

The Oasis Health Journal · Submitted July 31, 2026 · 12:30 PM EDT

By Deke Fontaine · Edited by Hal Weinstock

Pyridoxamine is a form of vitamin B6 that does not get enough credit for being mad at sugar. While pyridoxine, the common vitamin B6 supplement form, mostly stands around converting things, pyridoxamine actively blocks advanced glycation end products, which is the technical term for what happens when glucose sticks to your proteins and browns them like a pork chop left on the grill too long. Three studies published in 2026 measured this effect in actual tissue, and all three found the same thing: pyridoxamine stops glycation better than doing nothing, and in some comparisons better than pyridoxine, which is worth talking about because glycation is not a small problem.

Advanced glycation end products, AGEs for short because scientists also get tired, form when sugar molecules bond to proteins or fats without an enzyme supervising the reaction. It is the same chemistry that makes bread crust brown and makes barbecue taste like barbecue, except it is happening inside your blood vessels and your corneas and your heart valves, where you do not want things caramelizing. The process accelerates in high-sugar environments, which is why research on metabolic conditions is full of glycation papers and why pyridoxamine keeps showing up in those papers as the vitamer, the B6 form, that actually interferes with the reaction instead of just watching it happen.

Pyridoxamine vs Pyridoxine: What the Tissue Studies Measured

A 2026 study out of Acta Biomaterialia soaked strips of glutaraldehyde-treated cow pericardium, the tissue they use to build replacement heart valves, in a pyridoxamine derivative called Pyriphenone. The treated tissue accumulated significantly less AGE and significantly less serum albumin, the sticky protein that shows up wherever AGEs are having a party, compared to untreated tissue. They also implanted the treated tissue under the skin of juvenile rats for 28 days, and the pyridoxamine-modified material calcified less and took up less AGE than plain tissue. This was not a trial in humans taking a pill. This was tissue soaking in a pyridoxamine solution and then sitting in a live rat, but it directly measured AGE formation in a biological system, and the effect was significant.

The second study, published in Antioxidants, poisoned porcine uterine and oviduct cells with iodoacetic acid, a disinfection byproduct that inhibits a glycolysis enzyme and causes a pileup of reactive sugar intermediates that then glycate everything in reach. Pretreatment with pyridoxamine reduced the accumulation of a specific AGE called CML, carboxymethyllysine, and reduced cell death. The untreated cells showed mitochondrial dysfunction, calcium chaos and enough endoplasmic reticulum stress to trigger apoptosis. The pyridoxamine-pretreated cells had measurably less of all of that. Again, not a human taking a pyridoxamine supplement. Cells in a dish, dosed with poison, then measured. But the pyridoxamine blocked AGE formation at the tissue level under a stressor that directly causes glycation.

The third paper, from Investigative Ophthalmology and Visual Science, looked at mice with corneal wounds that were healing slowly, a common complication in research on metabolic dysfunction that correlates with AGE buildup in the cornea. One group got topical pyridoxamine to inhibit AGE formation. The treated mice showed faster wound closure and faster nerve regeneration compared to untreated controls. The study attributed the improvement to reduced AGE-driven inflammation through the TLR4 receptor pathway, which pyridoxamine appeared to calm down by stopping AGEs from accumulating in the first place.

Pyridoxamine AGE Blocking: The Chemistry That Actually Matters

Here is what pyridoxamine does that makes it different from pyridoxine supplements. Glycation starts when a sugar's aldehyde group reacts with an amino group on a protein, forming a Schiff base, which then rearranges into an Amadori product, which then, over weeks to months, becomes an AGE. Pyridoxamine has an amino group in a position that lets it intercept the reactive carbonyl intermediates before they finish turning into AGEs. It is a carbonyl scavenger. Pyridoxine does not have that geometry. It will eventually convert to pyridoxal phosphate and do all the normal B6 enzyme jobs, but it does not physically block the glycation reaction the way pyridoxamine does.

This is not me saying pyridoxamine is better than pyridoxine as a general B6 source. They do different things. Pyridoxine is cheaper, more stable on the shelf, and your liver will convert it to the active coenzyme forms your body actually uses for amino acid metabolism and neurotransmitter synthesis. Pyridoxamine has one specific trick, which is getting in the way of sugar damaging your proteins, and these three studies all measured that trick working in tissue.

Where to Buy Pyridoxamine Supplement and What the Dosage Research Does Not Tell You

You can find pyridoxamine supplements on the shelf next to the regular B6, usually in 50 mg or 100 mg capsules, and the label will not tell you what dose was used in any of these studies because none of these studies involved someone swallowing a pill. The cow valve study used tissue soaked in solution. The cell study pretreated cultures with pyridoxamine before poisoning them. The mouse cornea study applied pyridoxamine topically. There is no human pharmacokinetic data here that would let you back-calculate an oral dose that achieves the tissue concentration that blocked AGEs in these experiments.

That does not mean the research is useless. It means the research establishes a mechanism in living tissue under controlled conditions, and it does not establish an effective oral dose for a human trying to reduce systemic glycation. Those are two different questions. The mechanism data is solid. The dosing data for someone buying a bottle does not exist in these papers.

If you are comparing pyridoxamine vs B6 benefits, the clearest distinction is this: pyridoxamine appears to block AGE formation in tissue, pyridoxine does not, and all three 2026 studies measured that blocking effect in biological systems where glycation was happening in real time. Whether swallowing pyridoxamine at supplement doses produces the same tissue concentrations that worked in these models is a question these studies do not answer, and until someone publishes a trial in humans taking oral pyridoxamine and measuring circulating AGE levels before and after, we are still guessing at the dose.

Pyridoxamine P5P Alternative: Why the Name Is a Mess

Pyridoxamine is not a P5P alternative. P5P is pyridoxal 5-phosphate, the active coenzyme form of B6 that your cells use for about 140 different enzyme reactions. Pyridoxamine will eventually get phosphorylated and converted into pyridoxal phosphate in your liver, so in that sense every B6 vitamer is a P5P precursor, but calling pyridoxamine a P5P alternative like some supplement marketing does is like calling flour a bread alternative. Technically it becomes bread, but you have to do a bunch of steps first and the flour itself does not do what the bread does.

The reason to take pyridoxamine specifically, based on these studies, is the AGE-blocking effect that happens before it gets converted. Once it turns into P5P it is just doing regular B6 work. The glycation interference is a pyridoxamine-specific property that the other vitamers do not have, and conflating that with P5P is how you end up with people buying the wrong supplement for the effect they actually want.

If you are looking at glycation support, you want the actual pyridoxamine molecule in your tissue while the glycation reaction is trying to happen. If you want P5P because you read that it is the active form, just take P5P. They are not interchangeable, and the marketing that treats them as equivalent is selling you based on confusion.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Pyriphenone modification of glutaraldehyde pretreated bovine pericardium mitigates advanced glycation end products, calcification, and platelet adhesion, Acta biomaterialia (2026).
2. Glycation-Driven Mitochondrial and ER Stress Underlies Iodoacetic Acid-Induced Apoptosis in Porcine Uterus and Oviduct Epithelial Cells, Antioxidants (Basel, Switzerland) (2026).
3. Advanced Glycation End-Products Contribute to Delayed Diabetic Corneal Epithelial Wound Healing via the TLR4 Signaling, Investigative ophthalmology & visual science (2026).